Last 12 months
Inside the activity.
10 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 5 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2019 Filed Oct 3, 2019 20:13 UTC |
Brennan Daniel J.EVP and CFO
|
Exercise / conversionCommon Stock | 20,462 | $7.41 | $151,623.42 |
DisclosureSEC source: 0001225208-19-013151 · doc4.xml · nonDerivative · entry 1 Brennan Daniel J. · CIK 0001595612 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:13 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001225208-19-013150 · doc4.xml · derivative · entry 3 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,997 Underlying: Common Stock · 5,000 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:13 UTC |
Pierce David AEVP,Pres MedSurg
|
SaleCommon Stock | 5,000 | $41.14 | $205,685.50 |
DisclosureSEC source: 0001225208-19-013150 · doc4.xml · nonDerivative · entry 2 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,201 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.93 to $41.28, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:13 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionCommon Stock | 5,000 | $6.28 | $31,400.00 |
DisclosureSEC source: 0001225208-19-013150 · doc4.xml · nonDerivative · entry 1 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 20:25 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001225208-19-012123 · doc4.xml · derivative · entry 3 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,997 Underlying: Common Stock · 5,000 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 20:25 UTC |
Pierce David AEVP,Pres MedSurg
|
SaleCommon Stock | 5,000 | $42.50 | $212,500.00 |
DisclosureSEC source: 0001225208-19-012123 · doc4.xml · nonDerivative · entry 2 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,201 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 20:25 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionCommon Stock | 5,000 | $6.28 | $31,400.00 |
DisclosureSEC source: 0001225208-19-012123 · doc4.xml · nonDerivative · entry 1 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 34,035 | $0.00 Strike: $7.39 | $0.00 |
DisclosureSEC source: 0001225208-19-012044 · doc4.xml · derivative · entry 3 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,035 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
SaleCommon Stock | 34,035 | $42.65 | $1,451,422.58 |
DisclosureSEC source: 0001225208-19-012044 · doc4.xml · nonDerivative · entry 2 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,194 F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.51 to $42.75, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:10 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionCommon Stock | 34,035 | $7.39 | $251,518.65 |
DisclosureSEC source: 0001225208-19-012044 · doc4.xml · nonDerivative · entry 1 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:07 UTC |
Butcher Arthur CSVP&Pres, Endoscopy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,874 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001225208-19-011675 · doc4.xml · derivative · entry 4 Butcher Arthur C · CIK 0001678249 · SVP&Pres, Endoscopy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,874 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:07 UTC |
Butcher Arthur CSVP&Pres, Endoscopy
|
SaleCommon Stock | 6,329 | $41.98 | $265,680.03 |
DisclosureSEC source: 0001225208-19-011675 · doc4.xml · nonDerivative · entry 2 Butcher Arthur C · CIK 0001678249 · SVP&Pres, Endoscopy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,416 F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at $41.9537 and $41.9937. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:07 UTC |
Butcher Arthur CSVP&Pres, Endoscopy
|
Exercise / conversionCommon Stock | 3,874 | $7.16 | $27,737.84 |
DisclosureSEC source: 0001225208-19-011675 · doc4.xml · nonDerivative · entry 1 Butcher Arthur C · CIK 0001678249 · SVP&Pres, Endoscopy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 21:46 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
SaleCommon Stock | 6,000 | $42.79 | $256,757.40 |
DisclosureSEC source: 0001225208-19-011386 · doc4.xml · nonDerivative · entry 1 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,385 Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:07 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001225208-19-010843 · doc4.xml · derivative · entry 3 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,997 Underlying: Common Stock · 5,000 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:07 UTC |
Pierce David AEVP,Pres MedSurg
|
SaleCommon Stock | 5,000 | $42.62 | $213,091.50 |
DisclosureSEC source: 0001225208-19-010843 · doc4.xml · nonDerivative · entry 2 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,201 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.685, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 02, 2019 Filed Aug 5, 2019 20:07 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionCommon Stock | 5,000 | $6.28 | $31,400.00 |
DisclosureSEC source: 0001225208-19-010843 · doc4.xml · nonDerivative · entry 1 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| August 02, 2019 Filed Dec 16, 2019 21:08 UTC |
Carruthers WendySVP, Human Resources
|
GiftCommon Stock | 2,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015841 · doc4.xml · nonDerivative · entry 1 Carruthers Wendy · CIK 0001563565 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,848 Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:08 UTC |
Wang Xin WarrenSVP and Pres, Asia Pacific
|
GrantStock Option (Right to Buy) · Derivative | 40,849 | $0.00 Strike: $42.61 | $0.00 |
DisclosureSEC source: 0001225208-19-010844 · doc4.xml · derivative · entry 2 Wang Xin Warren · CIK 0001725283 · SVP and Pres, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,849 Underlying: Common Stock · 40,849 shares Expires 2029-08-01 F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal installments beginning on February 21, 2020 and continuing annually thereafter. The final vesting will occur on February 21, 2023. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:08 UTC |
Wang Xin WarrenSVP and Pres, Asia Pacific
|
GrantDeferred Stock Units · Derivative | 11,734 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-010844 · doc4.xml · derivative · entry 1 Wang Xin Warren · CIK 0001725283 · SVP and Pres, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,734 Underlying: Common Stock · 11,734 shares Expires 2023-02-21 F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal installments beginning on February 21, 2020 and continuing annually thereafter. The final vesting will occur on February 21, 2023. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal installments beginning on February 21, 2020 and continuing annually thereafter. The final vesting will occur on February 21, 2023. Read SEC document |
| July 30, 2019 Filed Dec 16, 2019 21:08 UTC |
Fitzgerald Joseph MichaelEVP & President, Rhythm Mgmt
|
GiftCommon Stock | 3,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-015842 · doc4.xml · nonDerivative · entry 1 Fitzgerald Joseph Michael · CIK 0001484186 · EVP & President, Rhythm Mgmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,685 Read SEC document |
| July 15, 2019 Filed Jul 16, 2019 20:13 UTC |
Sorenson John BradleySVP, Manuf & Sup Chn
|
SaleCommon Stock | 3,728 | $42.30 | $157,694.40 |
DisclosureSEC source: 0001225208-19-010253 · doc4.xml · nonDerivative · entry 1 Sorenson John Bradley · CIK 0001629277 · SVP, Manuf & Sup Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,385 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:07 UTC |
Fitzgerald Joseph MichaelEVP & President, Rhythm Mgmt
|
SaleCommon Stock | 20,673 | $43.41 | $897,414.93 |
DisclosureSEC source: 0001225208-19-009819 · doc4.xml · nonDerivative · entry 3 Fitzgerald Joseph Michael · CIK 0001484186 · EVP & President, Rhythm Mgmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,256 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:06 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001225208-19-009811 · doc4.xml · derivative · entry 3 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,997 Underlying: Common Stock · 5,000 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:06 UTC |
Pierce David AEVP,Pres MedSurg
|
SaleCommon Stock | 5,000 | $43.41 | $217,050.00 |
DisclosureSEC source: 0001225208-19-009811 · doc4.xml · nonDerivative · entry 2 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,201 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:06 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionCommon Stock | 5,000 | $6.28 | $31,400.00 |
DisclosureSEC source: 0001225208-19-009811 · doc4.xml · nonDerivative · entry 1 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:06 UTC |
Monson JonathanVP, Corp Controller and CAO
|
GrantStock Option (Right to Buy) · Derivative | 10,692 | $0.00 Strike: $42.90 | $0.00 |
DisclosureSEC source: 0001225208-19-009809 · doc4.xml · derivative · entry 2 Monson Jonathan · CIK 0001779170 · VP, Corp Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,692 Underlying: Common Stock · 10,692 shares Expires 2029-07-01 F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:06 UTC |
Monson JonathanVP, Corp Controller and CAO
|
GrantDeferred Stock Units · Derivative | 2,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-009809 · doc4.xml · derivative · entry 1 Monson Jonathan · CIK 0001779170 · VP, Corp Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,913 Underlying: Common Stock · 2,913 shares Expires 2023-07-01 F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant. F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:07 UTC |
Fitzgerald Joseph MichaelEVP & President, Rhythm Mgmt
|
SaleCommon Stock | 1,906 | $43.00 | $81,958.00 |
DisclosureSEC source: 0001225208-19-009819 · doc4.xml · nonDerivative · entry 2 Fitzgerald Joseph Michael · CIK 0001484186 · EVP & President, Rhythm Mgmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,929 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 20:23 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,039 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0001225208-19-009372 · doc4.xml · derivative · entry 3 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,039 shares Expires 2020-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual increments beginning on February 16, 2011, the first anniversary of the date of grant. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 20:23 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
SaleCommon Stock | 3,039 | $40.46 | $122,957.94 |
DisclosureSEC source: 0001225208-19-009372 · doc4.xml · nonDerivative · entry 2 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,469 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 20:23 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionCommon Stock | 3,039 | $7.41 | $22,518.99 |
DisclosureSEC source: 0001225208-19-009372 · doc4.xml · nonDerivative · entry 1 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 20:10 UTC |
Pierce David AEVP,Pres MedSurg
|
SaleCommon Stock | 1,650 | $38.60 | $63,684.06 |
DisclosureSEC source: 0001225208-19-008887 · doc4.xml · nonDerivative · entry 1 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,201 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.51 to $38.76, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:14 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,640 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001225208-19-008775 · doc4.xml · derivative · entry 8 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,640 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F6 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual increments beginning on February 28, 2012, the first anniversary of the grant. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:14 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001225208-19-008775 · doc4.xml · derivative · entry 7 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,997 Underlying: Common Stock · 2,500 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F5 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:14 UTC |
Pierce David AEVP,Pres MedSurg
|
SaleCommon Stock | 5,140 | $38.45 | $197,650.48 |
DisclosureSEC source: 0001225208-19-008775 · doc4.xml · nonDerivative · entry 5 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,851 F2 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.21 to $38.67, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:14 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionCommon Stock | 2,500 | $6.28 | $15,700.00 |
DisclosureSEC source: 0001225208-19-008775 · doc4.xml · nonDerivative · entry 4 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:14 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionCommon Stock | 2,640 | $7.16 | $18,902.40 |
DisclosureSEC source: 0001225208-19-008775 · doc4.xml · nonDerivative · entry 3 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:15 UTC |
Wang Xin WarrenSVP and Pres, Asia Pacific
|
SaleCommon Stock | 10,000 | $38.45 | $384,534.00 |
DisclosureSEC source: 0001225208-19-008777 · doc4.xml · nonDerivative · entry 1 Wang Xin Warren · CIK 0001725283 · SVP and Pres, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,469 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.21 to $38.65, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:14 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionDeferred Stock Units · Derivative | 2,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-008775 · doc4.xml · derivative · entry 6 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,945 Underlying: Common Stock · 2,972 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017. the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017. the first anniversary of the date of grant. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:14 UTC |
Pierce David AEVP,Pres MedSurg
|
Tax withholdingCommon Stock | 1,322 | $38.41 | $50,778.02 |
DisclosureSEC source: 0001225208-19-008775 · doc4.xml · nonDerivative · entry 2 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,851 Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:14 UTC |
Pierce David AEVP,Pres MedSurg
|
Exercise / conversionCommon Stock | 2,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-008775 · doc4.xml · nonDerivative · entry 1 Pierce David A · CIK 0001529751 · EVP,Pres MedSurg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:14 UTC |
Butcher Arthur CSVP&Pres, Endoscopy
|
Exercise / conversionDeferred Stock Units · Derivative | 1,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-008776 · doc4.xml · derivative · entry 4 Butcher Arthur C · CIK 0001678249 · SVP&Pres, Endoscopy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,523 Underlying: Common Stock · 1,761 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F4 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant. F4 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:14 UTC |
Butcher Arthur CSVP&Pres, Endoscopy
|
Tax withholdingCommon Stock | 518 | $38.41 | $19,896.38 |
DisclosureSEC source: 0001225208-19-008776 · doc4.xml · nonDerivative · entry 2 Butcher Arthur C · CIK 0001678249 · SVP&Pres, Endoscopy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,146 F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:14 UTC |
Butcher Arthur CSVP&Pres, Endoscopy
|
Exercise / conversionCommon Stock | 1,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-008776 · doc4.xml · nonDerivative · entry 1 Butcher Arthur C · CIK 0001678249 · SVP&Pres, Endoscopy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| May 29, 2019 Filed May 30, 2019 20:14 UTC |
Thepaut Eric Francis YvesSVP & Pres, Eur, Mid-East, Afr
|
SaleCommon Stock | 22,047 | $38.03 | $838,431.98 |
DisclosureSEC source: 0001225208-19-008635 · doc4.xml · nonDerivative · entry 1 Thepaut Eric Francis Yves · CIK 0001631992 · SVP & Pres, Eur, Mid-East, Afr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,977.99 F1 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.05, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 28, 2019 Filed May 29, 2019 20:16 UTC |
Eddy Jodi EuerleSVP and CIO
|
SaleCommon Stock | 7,803 | $38.42 | $299,792.04 |
DisclosureSEC source: 0001225208-19-008604 · doc4.xml · nonDerivative · entry 1 Eddy Jodi Euerle · CIK 0001734900 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,584 F1 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| May 15, 2019 Filed May 16, 2019 20:12 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,038 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0001225208-19-008111 · doc4.xml · derivative · entry 3 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,039 Underlying: Common Stock · 3,038 shares Expires 2020-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual increments beginning on February 16, 2011, the first anniversary of the date of grant. Read SEC document |
| May 15, 2019 Filed May 16, 2019 20:12 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
SaleCommon Stock | 3,038 | $36.74 | $111,616.12 |
DisclosureSEC source: 0001225208-19-008111 · doc4.xml · nonDerivative · entry 2 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,469 F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
| May 15, 2019 Filed May 16, 2019 20:12 UTC |
Nanavaty MaulikSVP & Pres, Neuromodulation
|
Exercise / conversionCommon Stock | 3,038 | $7.41 | $22,511.58 |
DisclosureSEC source: 0001225208-19-008111 · doc4.xml · nonDerivative · entry 1 Nanavaty Maulik · CIK 0001529708 · SVP & Pres, Neuromodulation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. F2 · balance_after: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.